B3GAT1 and myeloid sarcoma: We observed an increased percentage of CD57+ NK cells (p = 0.020) and NKT-like cells (p = 0.008) in CMV-seropositive MS patients compared to CMV-seronegative MS patients (Figure 2D and Figure 2F, respectively).